Kendall Law Group Investigates ZOLL Medical Corporation
13 Março 2012 - 12:20PM
Business Wire
Kendall Law Group, led by former federal judge Joe Kendall, is
investigating ZOLL Medical Corporation (NASDAQ:ZOLL) for
shareholders in connection with the proposed acquisition by Asahi
Kasei Corporation. The national securities firm’s investigation
seeks to determine whether ZOLL and its Board breached their
fiduciary duties by entering into the agreement without properly
shopping for a deal that would provide better value for
shareholders. If you are a ZOLL shareholder and would like
additional information about your rights, contact the Kendall Law
Group at 877-744-3728 or by email at
investor@kendalllawgroup.com.
On March 12, 2012, the companies announced the definitive merger
agreement under which ZOLL would be acquired by Asahi Kasei, in a
transaction valued at approximately $2.21 billion. Under the terms
of the agreement, ZOLL stockholders will receive $93.00 in cash for
each share of ZOLL common stock held. According to Thompson/First
Call, at least one analyst has set a price target of $100.00 per
share for ZOLL’s stock. The firm’s investigation seeks to determine
whether ZOLL and its Board undertook a fair process in negotiating
the deal.
Kendall Law Group was founded by a former federal judge,
includes a former United States Attorney, prosecutors and
securities lawyers who are experienced in complex securities
litigation. The firm has been counsel in numerous merger and
acquisition cases nationwide, including some of the largest
transactions in the United States.
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Zoll Medical Corp. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Kendall Law Group